Search research articles
Contact Us
Filters
Showing results (61-70 of 108) with videos related to
Page
of 11
Sort By:
Clinical Pharmacology and Therapeutics
|
September 1, 1982
Changes in ventricular septal thickness during diuretic therapy
J I Drayer, J M Gardin, M A Weber, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice
|
January 1, 1982
Reproducibility of the whole-day blood pressure pattern in essential hypertension
M A Weber, J I Drayer, F A Wyle, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 1980
Spironolactone and amiloride in hypertensive patients with and without aldosterone excess
W H Hoefnagels, J I Drayer, A G Smals, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1980
Divergent blood pressure responses during short-term sodium restriction in hypertension
D L Longworth, J I Drayer, M A Weber, et al.
Archives of Internal Medicine
|
May 1, 1983
Long-term BP monitoring in the evaluation of antihypertensive therapy
J I Drayer, M A Weber, J L DeYoung, et al.
Acta Endocrinologica
|
April 1, 1979
Pituitary-thyroid function in spironolactone treated hypertensive women
A G Smals, P W Kloppenborg, W H Hoefnagels, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice
|
January 1, 1982
The role of aldosterone in the response to treatment of primary hypertension
M A Weber, J I Drayer, R E Purdy, et al.
The American Journal of the Medical Sciences
|
March 1, 1983
Combined central and peripheral sympathetic blockade: absence of additive antihypertensive effects
F A Hubbell, M A Weber, J I Drayer, et al.
JAMA
|
October 1, 1982
A representative value for whole-day BP monitoring
M A Weber, J I Drayer, F A Wyle, et al.
The American Journal of the Medical Sciences
|
May 1, 1981
Low and high renin essential hypertension: a comparison of clinical and biochemical characteristics
J I Drayer, M A Weber, J E Sealey, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 108) with videos related to
Sort By:
Page
of 11
Clinical Pharmacology and Therapeutics
|
September 1, 1982
Changes in ventricular septal thickness during diuretic therapy
J I Drayer, J M Gardin, M A Weber, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice
|
January 1, 1982
Reproducibility of the whole-day blood pressure pattern in essential hypertension
M A Weber, J I Drayer, F A Wyle, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 1980
Spironolactone and amiloride in hypertensive patients with and without aldosterone excess
W H Hoefnagels, J I Drayer, A G Smals, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1980
Divergent blood pressure responses during short-term sodium restriction in hypertension
D L Longworth, J I Drayer, M A Weber, et al.
Archives of Internal Medicine
|
May 1, 1983
Long-term BP monitoring in the evaluation of antihypertensive therapy
J I Drayer, M A Weber, J L DeYoung, et al.
Acta Endocrinologica
|
April 1, 1979
Pituitary-thyroid function in spironolactone treated hypertensive women
A G Smals, P W Kloppenborg, W H Hoefnagels, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice
|
January 1, 1982
The role of aldosterone in the response to treatment of primary hypertension
M A Weber, J I Drayer, R E Purdy, et al.
The American Journal of the Medical Sciences
|
March 1, 1983
Combined central and peripheral sympathetic blockade: absence of additive antihypertensive effects
F A Hubbell, M A Weber, J I Drayer, et al.
JAMA
|
October 1, 1982
A representative value for whole-day BP monitoring
M A Weber, J I Drayer, F A Wyle, et al.
The American Journal of the Medical Sciences
|
May 1, 1981
Low and high renin essential hypertension: a comparison of clinical and biochemical characteristics
J I Drayer, M A Weber, J E Sealey, et al.
Page
of 11